BTWING

Welcome to the Brand page for “BTWING”, which is offered here for Recombinant monoclonal antibody directed against cd 20, for disease testing and medical treatment use;bt wing; biotechnologies wing;.

Its status is currently believed to be active. Its class is unavailable. “BTWING” is believed to be currently owned by “Laboratoire Français; du Fractionnementet des Biotechnologies”.


Owner:
LABORATOIRE FRANÇAIS; DU FRACTIONNEMENTET DES BIOTECHNOLOGIES
Owner Details
Description:
Recombinant monoclonal antibody directed against CD 20, for disease testing and medical treatment use;BT WING; BIOTECHNOLOGIES WING;
Categories: RECOMBINANT MONOCLONAL ANTIBODY DIRECTED AGAINST